// App-Quantinova.ai

: Single cell phenogenomic subtyping of circulating tumor cells (CTCs) identify intercellular tumor heterogeneity (het) and multiple resistance mechansisms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Howard I. Scher

Principal Investigators

  • Ryon Graf

  • Adam Jendrisak

  • Nicole A. Schreiber

  • Brigit McLaughlin

  • Stephanie Greene

  • Angel Rodriguez

  • Martin Fleisher

  • Jerry Lee

  • James Kelvin

  • Yipeng Wang

  • Mark Andrew Landers

  • Ryan Vance Dittamore

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Epic Sciences, Inc., San Diego, CA

Locations

  • United States

Companies

  • EPIC SCIENCES, INC.

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved